VIRAFERON Side Effects

6504260-2 | Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Cardiac Failure, Dialysis, Haptoglobin Decreased, Hypercalcaemia, Malignant Hypertension
on Dec 11, 2009 Male patient from FRANCE , 36 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Viraferon (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood pressure increased, cardiac failure, dialysis (What is dialysis?), haptoglobin decreased, hypercalcaemia, malignant hypertension. Viraferon dosage: 3 Miu;tiw. During the same period patient was treated with RIBAVIRIN (1000 Mg;qd) (View Ribavirin Review and Ribavirin Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), AMLOR (View Amlor Review and Amlor Label ), ZESTRIL (View Zestril Review and Zestril Label ), ATACAND (View Atacand Review and Atacand Label ), EUCALCIC (View Eucalcic Review and Eucalcic Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6472706-4 | Cough, Left Ventricular Failure, Malignant Hypertension, Nephroangiosclerosis, Renal Failure Acute, Thrombotic Microangiopathy, Tobacco Poisoning
Patient was taking Viraferon (View Usage). Patient had the following side effects: cough, left ventricular failure, malignant hypertension, nephroangiosclerosis, renal failure acute, thrombotic microangiopathy, tobacco poisoning on Nov 26, 2009 from FRANCE Additional patient health information: Male patient , 36 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Viraferon dosage: 3 Miu;tiw;. During the same period patient was treated with RIBAVIRIN (1000 Mg;qd;) (View Ribavirin Review and Ribavirin Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), AMLOR (View Amlor Review and Amlor Label ), ZESTRIL (View Zestril Review and Zestril Label ), ATACAND (View Atacand Review and Atacand Label ), EUCALCIC (View Eucalcic Review and Eucalcic Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6024269-5 | Cytolytic Hepatitis, Hepatitis Toxic, Influenza, Neutropenia, Thrombocytopenia
Adverse event was reported on Dec 17, 2008 by a Female patient taking Viraferon (View Usage) (Dosage: 350 Mg; Qw; Sc) was diagnosed with malignant melanoma and. Location: FRANCE , 33 years of age, After Viraferon was administered, patient had the following side effects: cytolytic hepatitis, hepatitis toxic, influenza, neutropenia, thrombocytopenia. During the same period patient was treated with STABLON (View Stablon Review and Stablon Label ), XANAX (View Xanax Review and Xanax Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ), VOGALENE (View Vogalene Review and Vogalene Label ). Patient was hospitalized.

5940275-0 | Activities Of Daily Living Impaired, Cerebrovascular Disorder, Demyelination, Depression, Impaired Driving Ability, Impaired Work Ability, Movement Disorder, Optic Atrophy
on Oct 22, 2008 Male patient from FRANCE , 54 years of age, weighting 231.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Viraferon (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, cerebrovascular disorder, demyelination, depression (What is depression?), impaired driving ability, impaired work ability, movement disorder (What is movement disorder?), optic atrophy. Viraferon dosage: 800 Mcg;qw;sc 150;qw; Sc. During the same period patient was treated with REBETOL (800 Mg;qd;po) (View Rebetol Review and Rebetol Label ), PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized and became disabled.


5839415-3 | Eczema, Erythema, Glossodynia, Hypothyroidism, Mouth Ulceration, Muscular Weakness, Paraesthesia, Pruritus, Rash Papular
on Apr 18, 2008 Male patient from FRANCE , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Viraferon (View Usage). Patient had the following side effects: eczema (What is eczema?), erythema, glossodynia, hypothyroidism, mouth ulceration, muscular weakness, paraesthesia, pruritus, rash papular. Viraferon dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), LAROXYL (CON.) (View Laroxyl (con.) Review and Laroxyl (con.) Label ), KEPPRA (CON.) (View Keppra (con.) Review and Keppra (con.) Label ), DEXERYL (CON.) (View Dexeryl (con.) Review and Dexeryl (con.) Label ), ATARAX (CON.) (View Atarax (con.) Review and Atarax (con.) Label ), NERISONE (CON.) (View Nerisone (con.) Review and Nerisone (con.) Label ), AERIUS (CON.) (View Aerius (con.) Review and Aerius (con.) Label ), TRIDESONIT (CON.) (View Tridesonit (con.) Review and Tridesonit (con.) Label ). Patient was hospitalized.

5741409-3 | Atrioventricular Block Complete, Feeling Abnormal
Patient was taking Viraferon (View Usage). After Viraferon was administered, patient had the following side effects: atrioventricular block complete, feeling abnormal on May 07, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 51 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Viraferon dosage: . During the same period patient was treated with REBETOL (View Rebetol Review and Rebetol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5731152-9 | Colon Cancer
Adverse event was reported on Apr 30, 2008 by a Male patient taking Viraferon (View Usage) (Dosage: 3 Miu; Biw; Sc) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED KINGDOM , 57 years of age, weighting 218.3 lb, Patient experienced the following unwanted or unexpected effects: colon cancer. During the same period patient was treated with REBETOL (600 Mg; Bid; Po) (View Rebetol Review and Rebetol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5719087-9 | Eczema, Erythema, Glossodynia, Hypothyroidism, Mouth Ulceration, Muscular Weakness, Palatal Disorder, Pruritus, Rash Papular
on Apr 18, 2008 Male patient from FRANCE , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?), epilepsy (What is epilepsy?) and was treated with Viraferon (View Usage). Patient had the following side effects: eczema (What is eczema?), erythema, glossodynia, hypothyroidism, mouth ulceration, muscular weakness, palatal disorder, pruritus, rash papular. Viraferon dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), LAMICTAL (Po) (View Lamictal Review and Lamictal Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ), KEPPRA (View Keppra Review and Keppra Label ), DEXERYL (View Dexeryl Review and Dexeryl Label ), ATARAX (View Atarax Review and Atarax Label ), NERISONE (View Nerisone Review and Nerisone Label ), AERIUS (View Aerius Review and Aerius Label ). Patient was hospitalized.

5616685-8 | Pulmonary Interstitial Emphysema Syndrome
on Jan 31, 2008 Male patient from FRANCE , 48 years of age, weighting 264.6 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Viraferon (View Usage). After Viraferon was administered, patient had the following side effects: pulmonary interstitial emphysema syndrome. Viraferon dosage: Sc. During the same period patient was treated with COPEGUS (Po) (View Copegus Review and Copegus Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), ATARAX (View Atarax Review and Atarax Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), IMOVANE (View Imovane Review and Imovane Label ), NOCTAMIDE (View Noctamide Review and Noctamide Label ). Patient was hospitalized.

5599686-8 | Pulmonary Interstitial Emphysema Syndrome
Patient was taking Viraferon (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary interstitial emphysema syndrome on Jan 10, 2008 from FRANCE Additional patient health information: Male patient , 48 years of age, weighting 264.6 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Viraferon dosage: ;po. During the same period patient was treated with COPEGUS (;po) (View Copegus Review and Copegus Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), ATARAX (View Atarax Review and Atarax Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), IMOVANE (View Imovane Review and Imovane Label ), NOCTAMIDE (View Noctamide Review and Noctamide Label ). Patient was hospitalized.

5336408-X | Anaemia, Cutaneous Vasculitis, Neutropenia, Polyarthritis
Adverse event was reported on May 11, 2007 by a Female patient taking Viraferon (View Usage) (Dosage: Sc) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 54 years of age, Patient had the following side effects: anaemia, cutaneous vasculitis, neutropenia, polyarthritis. During the same period patient was treated with REBETOL (Po) (View Rebetol Review and Rebetol Label ), EPREX (View Eprex Review and Eprex Label ), ANTIRETROVIRAL TREATMENT (View Antiretroviral Treatment Review and Antiretroviral Treatment Label ). Patient was hospitalized.